These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27921141)

  • 21. [Metabolic syndrome and nephrolithiasis].
    Kohjimoto Y; Iba A; Sasaki Y; Hara I
    Hinyokika Kiyo; 2011 Jan; 57(1):43-7. PubMed ID: 21304261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pathophysiology, diagnosis and conservative therapy of non-calcium kidney calculi].
    Hochreiter W; Knoll T; Hess B
    Ther Umsch; 2003 Feb; 60(2):89-97. PubMed ID: 12649987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical and metabolic features of renal calculi in adults in regard to age of onset].
    Vitale C; Tricerri A; Manganaro M; Bagnis C; Bruno M; Marangella M; Ramello A
    Minerva Urol Nefrol; 1999 Jun; 51(2):71-4. PubMed ID: 10429414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnosis and prevention of uric acid stones].
    Ferrari P; Bonny O
    Ther Umsch; 2004 Sep; 61(9):571-4. PubMed ID: 15493118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic syndrome and the genesis of uric acid stones.
    Maalouf NM
    J Ren Nutr; 2011 Jan; 21(1):128-31. PubMed ID: 21195936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Idiopathic recurrent calcium urolithiasis (IRCU): an acid meal challenge uncovers inappropriate pH of postprandial, fasting and daily urine: a cross-sectional study of male patients providing insight into post- and pre-load urinary stone substances, crystallization risk, presence of stones, renal transport and systemic metabolic factors.
    Schwille PO; Wipplinger J
    Eur J Med Res; 2008 Jul; 13(7):332-42. PubMed ID: 18700191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A London experience 1995-2012: demographic, dietary and biochemical characteristics of a large adult cohort of patients with renal stone disease.
    Ferraro PM; Robertson WG; Johri N; Nair A; Gambaro G; Shavit L; Moochhala SH; Unwin RJ
    QJM; 2015 Jul; 108(7):561-8. PubMed ID: 25524906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A role of fructose in urinary stone formation].
    Pavlova ZS; Golodnikov II; Kamalov AA; Nizov AN
    Urologiia; 2019 Apr; (1):114-118. PubMed ID: 31184028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic syndrome and stone disease.
    Soligo M; Morlacco A; Zattoni F; Valotto C; DE Giorgi G; Beltrami P
    Panminerva Med; 2022 Sep; 64(3):344-358. PubMed ID: 34609121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Uric acid nephrolithiasis].
    Ferraro PM; Gambaro G
    G Ital Nefrol; 2015; 32 Suppl 62():. PubMed ID: 26005875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Weight loss intervention reduces the risk of kidney stone formation in a rat model of metabolic syndrome.
    Sasaki Y; Kohjimoto Y; Iba A; Matsumura N; Hara I
    Int J Urol; 2015 Apr; 22(4):404-9. PubMed ID: 25586245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of visceral fat area and other metabolic parameters on stone composition in patients undergoing percutaneous nephrolithotomy.
    Zhou T; Watts K; Agalliu I; DiVito J; Hoenig DM
    J Urol; 2013 Oct; 190(4):1416-20. PubMed ID: 23685097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local factors compared with systemic factors in the formation of bladder uric acid stones.
    Li WM; Chou YH; Li CC; Liu CC; Huang SP; Wu WJ; Huang CH
    Urol Int; 2009; 82(1):48-52. PubMed ID: 19172097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uric acid stones following hepatic transplantation.
    Hwang MT; Goldfarb DS
    Urol Res; 2004 Dec; 32(6):423-6. PubMed ID: 15565437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Functional evaluation in patients with kidney calculi].
    Stojimirović B
    Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic syndrome and urinary stone composition: what factors matter most?
    Kadlec AO; Greco K; Fridirici ZC; Hart ST; Vellos T; Turk TM
    Urology; 2012 Oct; 80(4):805-10. PubMed ID: 22795374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mineral composition of renal stones from the Sudan.
    Balla AA; Salah AM; Khattab AH; Kambal A; Bongartz D; Hoppe B; Hesse A
    Urol Int; 1998; 61(3):154-6. PubMed ID: 9933835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of the National Health and Nutrition Examination Survey to calculate the impact of obesity and diabetes on cost and prevalence of urolithiasis in 2030.
    Antonelli JA; Maalouf NM; Pearle MS; Lotan Y
    Eur Urol; 2014 Oct; 66(4):724-9. PubMed ID: 25015037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.